ARCHIVES

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho

October 26, 2012

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

“Over-Regulation” Threatens Health Care, Thompson Says.

June 15, 2001

Moratorium Asked On New Bladder Cancer Screening

January 27, 1978

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977